Enliven Therapeutics
ELVN
#5632
Rank
$0.91 B
Marketcap
$18.65
Share price
-1.37%
Change (1 day)
4.83%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : $15.91 Million USD

According to Enliven Therapeutics's latest financial reports the company's total liabilities are $15.91 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31$15.91 M-38.7%
2023-12-31$25.96 M-83.79%
2022-12-31$0.16 B2.5%
2021-12-31$0.15 B3.24%
2020-12-31$0.15 B